Endogenous vascular remodeling in ischemic skeletal muscle: A role for nitric oxide

Journal of Applied Physiology

Volumn 94, Issue 3, 2003, Pages 935-940

  Buckwalter, John B ^a   Curtis, Valerie C ^a   Valic, Zoran ^a   Ruble, Stephen B ^a   Clifford, Philip S ^a  

^a CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Angiogenesis; Arteriogenesis; Blood flow; Exercise; Rabbits

Indexed keywords

N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOVASCULAR SYSTEM; CONTROLLED STUDY; ENZYME INHIBITION; ILIAC ARTERY; LIMB BLOOD FLOW; LIMB ISCHEMIA; MUSCLE ISCHEMIA; NONHUMAN; PRIORITY JOURNAL; RABBIT; TREADMILL EXERCISE; VOLUNTARY MOVEMENT;

EID: 0037372559     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/japplphysiol.00378.2002     Document Type: Article

References (39)

1. Arras M, Ito WD, Scholz D, Winkler B, Schaper J, and Schaper W. Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb. J Clin Invest 101: 40-50, 1997.
2. Asahara T, Bauters C, Zheng LP, Takesthita S, Bunting S, Ferrara N, Symes JF, and Isner JM. Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation 92, Suppl II: II-365-II-371, 1995.
3. Baffour R, Berman J, Garb JL, Rhee SW, Kaufman J, and Friedmann P. Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia: dose-response effect of basic fibroblast growth factor. J Vasc Surg 16: 181-191, 1992.
4. Bauters G, Asahara T, Zheng LP, Takeshita S, Bunting S, Ferrara N, Symes JF, and Isner JM. Physiological assessment of augmented vascularity induced by VEGF in ischemic rabbit hindlimb. Am J Physiol Heart Circ Physiol 267: H1263-H1271, 1994.
5. Bauters C, Asahara T, Zheng LP, Takeshita S, Bunting S, Ferrara N, Symes JF, and Isner JM. Recovery of disturbed endothelium-dependent flow in the collateral-perfused rabbit ischemic hindlimb after administration of vascular endothelial growth factor. Circulation 91: 2802-2809, 1995.
6. Boussairi EH and Sassard J. Cardiovascular effects of basic fibroblast growth factor. J Cardiovasc Pharmacol 23: 99-102, 1994.
7. Buschmann I and Schaper W. Arteriogenesis versus angiogenesis: two mechanisms of vessel growth. News Physiol Sci 14: 121-125, 1999.
8. Cueva P, Carceller F, Ortega S, Zazo M, Nieto I, and Gimenez-Gallego G. Hypotensive activity of fibroblast growth factor. Science 254: 1208-1210, 1991.
9. Dahllof AG, Holm J, Schersten T, and Sivertsson R. Peripheral arterial insufficiency. Effect of physical training on walking tolerance, calf blood flow and blood flow resistance. Scand J Rehabil Med 8: 19-26, 1976.
10. Ekroth R, Dahllof AG, Gunderall B, Holm J, and Schersten T. Physical training of patients with intermittent claudication: indications, methods and results. Surgery 84: 640-643, 1978.
11. Folkman J and Shing Y. Angiogenesis. J Biol Chem 267: 10931-10934, 1992.
12. Fox JC and Swain JL. Angiogenic gene therapy: a leg to stand on? Circulation 94: 3065-3066, 1996.
13. Girolami B, Bernardi E, Prins MH, Ten Cate JW, Hettiarachchi R, Prandoni P, Girolami A, and Buller HR. Treatment of intermittent claudication with physical training, smoking cessation, pentoxifylline, or nafronyl: a meta-analysis. Arch Intern Med 159: 337-345, 1999.
14. Hopkins SP, Bulgrin JP, Sims RL, Bowman B, Donovan DL, and Schmidt SP. Controlled delivery of vascular endothelial growth factor promotes neovascularization and maintains limb function in a rabbit model of ischemia. J Vasc Surg 27: 886-895, 1998.
15. Hudlicka O, Brown M, and Egginton S. Angiogenesis in skeletal muscle and cardiac muscle. Physiol Rev 72: 369-417, 1992.
16. G-nitro-L-arginine, nitric oxide synthase inhibitor. Microvasc Res 59: 45-51, 2000.
17. Ito WD, Arras M, Scholz D, Winkler B, Thun P, and Schaper W. Angiogenesis but not collateral growth is associated with ischemia after femoral artery occlusion. Am J Physiol Heart Circ Physiol 273: H1255-H1265, 1997.
18. Ito W, Arras M, Winkler B, Scholz D, Schaper J, and Schaper W. Monocyte chemotactic protein-1 increases collateral and peripheral conductance after femoral artery occlusion. Circ Res 80: 829-837, 1997.
19. Lloyd PG, Yang HT, and Terjung RL. Arteriogenesis and angiogenesis in rat ischemic hindlimb: role of nitric oxide. Am J Physiol Heart Circ Physiol 281: H2528-H2538, 2001.
20. Mathien GM and Terjung RL. Influence of training following bilateral stenosis of the femoral artery in rats. Am J Physiol Heart Circ Physiol 250: H1050-H1059, 1986.
21. Mathien GM and Terjung RL. Muscle blood flow in trained rats with peripheral arterial insufficiency. Am J Physiol Heart Circ Physiol 258: H759-H765, 1990.
22. Melkumyants AM, Balashov SS, and Khayutin VM. Control of arterial lumen by shear stress on endothelium. News Physiol Sci 10: 204-210, 1995.
23. Montrucchio G, Lupia E, De Martino A, Battaglia E, Arese M, Tizzani A, Bussolino F, and Camussi G. Nitric oxide mediates angiogenesis induced in vivo by platelet-activating factor and tumor necrosis factor-α. Am J Pathol 151: 557-563, 1997.
24. Murohara T, Asahara T, Silver M, Bauters C, Masuda H, Kalka C, Kearney M, Chen D, Symes JF, Fishman MC, Huang PL, and Isner JM. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest 101: 2567-2578, 1998.
25. Neufeld G, Cohen T, Gengrinovitch S, and Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 13: 9-22, 1999.
26. Phillips GD, Fiegel VD, and Knighton DR. Putative angiogenesis factors: a review. Wounds 4: 94-97, 1992.
27. Pinckard RN, Woodard DS, Showell HJ, Conklyn MJ, Novak MN, and McManus L. Structural and (patho)physiological diversity of PAF. Clin Res Allergy 12: 329-359, 1994.
28. Pohl U and deWit C. A unique role of NO in the control of blood flow. News Physiol Sci 14: 74-79, 1999.
29. Pu L, Jackson S, Lachapelle KJ, Arekat Z, Graham AM, Lisbona R, and Brassard R. A persistent hindlimb ischemia model in the rabbit. J Invest Surg 7: 49-60, 1994.
30. Shweiki D, Itin A, Soffer D, and Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359: 843-845, 1992.
31. Takeshita S, Pu L, Stein LA, Sniderman AD, Bunting S, Ferrara N, Isner JM, and Symes JF. Intramuscular administration of vascular endothelial growth factor induces dose-dependent collateral artery augmentation in a rabbit model of chronic limb ischemia. Circulation 90: 228-234, 1994.
32. Takeshita S, Zheng LP, Brogi E, Kearney M, Bunting S, Ferrara N, Symes JF, and Isner JM. Therapeutic angiogenesis: a single intra-arterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hindlimb model. J Clin Invest 93: 662-670, 1994.
33. Tronc F, Wassef M, Esposito B, Henrion D, Glagov S, and Tedgui A. Role of NO in flow-induced remodeling of the rabbit common carotid artery. Arterioscler Thromb Vasc Biol 16: 1256-1262, 1996.
34. Van der Zee R, Murohara T, Luo Z, Zollmann F, Passeri J, Lekutat C, and Isner JM. Vascular endothelial growth factor/vascular permeability factor augments nitric oxide release from quiescent rabbit and human vascular endothelium. Circulation 95: 1030-1037, 1997.
35. Van Royen N, Piek JJ, Buschmann I, Hoefer I, Voskuil M, and Schaper W. Stimulation of arteriogenesis: a new concept for the treatment of arterial occlusive disease. Cardiovasc Res 49: 543-553, 2001.
36. Yang HT, Ogilvie RW, and Terjung RL. Training increases collateral-dependent muscle blood flow in aged rats. Am J Physiol Heart Circ Physiol 268: H1174-H1180, 1995.
37. Yang HT, Ogilvie RW, and Terjung RL. Low-intensity training produces muscle adaptations in rats with femoral artery stenosis. J Appl Physiol 71: 1822-1829, 1991.
38. 1-blocker prazosin on capillary density in cardiac and skeletal muscle. Pflügers Arch 415: 355-360, 1989.
39. Ziche M, Mordelli L, Masini E, Amerini S, Granger JJ, Maggi CA, Geppetti P, and Ledda F. Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J Clin Invest 94: 2036-2044, 1994.